Drug-like Density: A Method of Quantifying the "Bindability" of a Protein Target Based on a Very Large Set of Pockets and Drug-like Ligands from the Protein Data Bank

被引:86
|
作者
Sheridan, Robert P. [1 ]
Maiorov, Vladimir N. [1 ]
Holloway, M. Katharine [2 ]
Cornell, Wendy D. [1 ]
Gao, Ying-Duo [1 ]
机构
[1] Merck Res Labs, Chem Modeling & Informat Dept, Rahway, NJ 07065 USA
[2] Merck Res Labs, Chem Modeling & Informat Dept, West Point, PA 19486 USA
关键词
BINDING-SITES; DRUGGABLE GENOME; STRAND TRANSFER; IDENTIFICATION; EXPLORATION; OPINION; DESIGN; SPACE; MODEL; INDEX;
D O I
10.1021/ci100312t
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
One approach to estimating the "chemical tractability" of a candidate protein target where we know the atomic resolution structure is to examine the physical properties of potential binding sites. A number of other workers have addressed this issue. We characterize similar to 290 000 "pockets" from similar to 42 000 protein crystal structures in terms of a three parameter "pocket space": volume, buriedness, and hydrophobicity. A metric DUD (drug-like density) measures how likely a pocket is to bind a drug-like molecule. This is calculated from the count of other pockets in its local neighborhood in pocket space that contain drug-like cocrystallized ligands and the count of total pockets in the neighborhood. Surprisingly, despite being defined locally, a global trend in DUD can be predicted by a simple linear regression on log(volume), buriedness, and hydrophobicity. Two levels of simplification are necessary to relate the DUD of individual pockets to "targets": taking the best DUD per Protein Data Bank (PDB) entry (because any given crystal structure can have many pockets), and taking the median DUD over all PDB entries for the same target (because different crystal structures of the same protein can vary because of artifacts and real conformational changes). We can show that median DLIDs for targets that are detectably homologous in sequence are reasonably similar and that median DLIDs correlate with the "druggability" estimate of Cheng et al. (Nature Biotechnology 2007, 25, 71-75).
引用
收藏
页码:2029 / 2040
页数:12
相关论文
共 16 条
  • [1] DiPPI: A Curated Data Set for Drug-like Molecules in Protein-Protein Interfaces
    Cankara, Fatma
    Senyuz, Simge
    Sayin, Ahenk Zeynep
    Gursoy, Attila
    Keskin, Ozlem
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2024, 64 (13) : 5041 - 5051
  • [2] Predicting protein targets for drug-like compounds using transcriptomics
    Pabon, Nicolas A.
    Xia, Yan
    Estabrooks, Samuel K.
    Ye, Zhaofeng
    Herbrand, Amanda K.
    Suss, Evelyn
    Biondi, Ricardo M.
    Assimon, Victoria A.
    Gestwicki, Jason E.
    Brodsky, Jeffrey L.
    Camacho, Carlos J.
    Bar-Joseph, Ziv
    PLOS COMPUTATIONAL BIOLOGY, 2018, 14 (12)
  • [3] Study of G protein-coupled receptors dimerization: From bivalent ligands to drug-like small molecules
    Qian, Mingcheng
    Sun, Zhengyang
    Chen, Xin
    Van Calenbergh, Serge
    BIOORGANIC CHEMISTRY, 2023, 140
  • [4] Target-Based Evaluation of "Drug-Like" Properties and Ligand Efficiencies
    Leeson, Paul D.
    Bento, A. Patricia
    Gaulton, Anna
    Hersey, Anne
    Manners, Emma J.
    Radoux, Chris J.
    Leach, Andrew R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (11) : 7210 - 7230
  • [5] Wrapping mimicking in drug-like small molecules disruptive of protein-protein interfaces
    Accordino, Sebastian R.
    Morini, Marcela A.
    Sierra, Maria Belen
    Fris, J. Ariel Rodriguez
    Appignanesi, Gustavo A.
    Fernandez, Ariel
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2012, 80 (07) : 1755 - 1765
  • [6] Rational design of drug-like compounds targeting Mycobacterium marinum MelF protein
    Dharra, Renu
    Talwar, Sakshi
    Singh, Yogesh
    Gupta, Rani
    Cirillo, Jeffrey D.
    Pandey, Amit K.
    Kulharia, Mahesh
    Mehta, Promod K.
    PLOS ONE, 2017, 12 (09):
  • [7] Virtual Screening of Drug-Like Compounds as Potential Inhibitors of the Dengue Virus NS5 Protein
    Garcia-Ariza, Leidy L.
    Rocha-Roa, Cristian
    Padilla-Sanabria, Leonardo
    Castano-Osorio, Jhon C.
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [8] Estimation of the size of drug-like chemical space based on GDB-17 data
    Polishchuk, P. G.
    Madzhidov, T. I.
    Varnek, A.
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2013, 27 (08) : 675 - 679
  • [9] Design of Drug-Like Protein-Protein Interaction Stabilizers Guided By Chelation-Controlled Bioactive Conformation Stabilization
    Bosica, Francesco
    Andrei, Sebastian A.
    Neves, Joao Filipe
    Brandt, Peter
    Gunnarsson, Anders
    Landrieu, Isabelle
    Ottmann, Christian
    O'Mahony, Gavin
    CHEMISTRY-A EUROPEAN JOURNAL, 2020, 26 (31) : 7131 - 7139
  • [10] CProMG: controllable protein-oriented molecule generation with desired binding affinity and drug-like properties
    Li, Jia-Ning
    Yang, Guang
    Zhao, Peng-Cheng
    Wei, Xue-Xin
    Shi, Jian-Yu
    BIOINFORMATICS, 2023, 39 : i326 - i336